Cite
HARVARD Citation
Boinpally, R. et al. (2021). A Single Supratherapeutic Dose of Atogepant Does Not Affect Cardiac Repolarization in Healthy Adults: Results From a Randomized, Single‐Dose, Phase 1 Crossover Trial. Clinical pharmacology in drug development. 10 (9), pp. 1099-1107. [Online].